| Microvesicles: mediators of extracellular communication during cancer progression V Muralidharan-Chari, JW Clancy, A Sedgwick, C D'Souza-Schorey Journal of cell science 123 (10), 1603-1611, 2010 | 1144 | 2010 |
| ARF6-regulated shedding of tumor cell-derived plasma membrane microvesicles V Muralidharan-Chari, J Clancy, C Plou, M Romao, P Chavrier, G Raposo, ... Current Biology 19 (22), 1875-1885, 2009 | 942 | 2009 |
| ADP-ribosylation factor 6 regulates tumor cell invasion through the activation of the MEK/ERK signaling pathway SE Tague, V Muralidharan, C D'Souza-Schorey Proceedings of the National Academy of Sciences 101 (26), 9671-9676, 2004 | 202 | 2004 |
| Purα is essential for postnatal brain development and developmentally coupled cellular proliferation as revealed by genetic inactivation in the mouse K Khalili, L Del Valle, V Muralidharan, WJ Gault, N Darbinian, J Otte, ... Molecular and cellular biology 23 (19), 6857-6875, 2003 | 188 | 2003 |
| Regulated delivery of molecular cargo to invasive tumour-derived microvesicles JW Clancy, A Sedgwick, C Rosse, V Muralidharan-Chari, G Raposo, ... Nature communications 6 (1), 6919, 2015 | 183 | 2015 |
| ADP-ribosylation factor 6 regulates tumorigenic and invasive properties in vivo V Muralidharan-Chari, H Hoover, J Clancy, J Schweitzer, MA Suckow, ... Cancer research 69 (6), 2201-2209, 2009 | 130 | 2009 |
| Microvesicle removal of anticancer drugs contributes to drug resistance in human pancreatic cancer cells V Muralidharan-Chari, HG Kohan, AG Asimakopoulos, T Sudha, S Sell, ... Oncotarget 7 (31), 50365, 2016 | 80 | 2016 |
| Evidence that replication of human neurotropic JC virus DNA in glial cells is regulated by the sequence-specific single-stranded DNA-binding protein Pur alpha CF Chang, GL Gallia, V Muralidharan, NN Chen, P Zoltick, E Johnson, ... Journal of virology 70 (6), 4150-4156, 1996 | 74 | 1996 |
| Thymoquinone Modulates Blood Coagulation in Vitro via Its Effects on Inflammatory and Coagulation Pathways V Muralidharan-Chari, J Kim, A Abuawad, M Naeem, H Cui, SA Mousa International journal of molecular sciences 17 (4), 474, 2016 | 36 | 2016 |
| Evidence for inhibition of MyEF‐2 binding to MBP promoter by MEF‐1/Pur α V Muralidharan, A Tretiakova, A Steplewski, S Haas, S Amini, E Johnson, ... Journal of cellular biochemistry 66 (4), 524-531, 1997 | 36 | 1997 |
| Method M, Chavrier P, D’Souza-Schorey C JW Clancy, A Sedgwick, C Rosse, V Muralidharan-Chari, G Raposo Regulated delivery of molecular cargo to invasive tumour-derived …, 2015 | 35 | 2015 |
| Investigating the role of ADP‐ribosylation factor 6 in tumor cell invasion and extracellular signal‐regulated kinase activation H Hoover, V Muralidharan‐Chari, S Tague, C D'Souza‐Schorey Methods in enzymology 404, 134-147, 2005 | 28 | 2005 |
| Modulation of sickle red blood cell adhesion and its associated changes in biomarkers by sulfated nonanticoagulant heparin derivative A Alshaiban, V Muralidharan-Chari, A Nepo, SA Mousa Clinical and Applied Thrombosis/Hemostasis 22 (3), 230-238, 2016 | 19 | 2016 |
| Regulation of Purα gene transcription: Evidence for autoregulation of Purα promoter V Muralidharan, T Sweet, Y Nadraga, S Amini, K Khalili Journal of cellular physiology 186 (3), 406-413, 2001 | 16 | 2001 |
| Molecular characterization and chromosomal localization of mouse Purα gene V Muralidharan, L Cort, E Meier, EP Blankenhorn, K Khalili Journal of cellular biochemistry 77 (1), 1-5, 2000 | 9 | 2000 |
| Reversal of anticoagulant activity of heparin and low molecular weight heparins by poly-l-lysine: A comparative ‘in vitro’study versus protamine sulfate V Muralidharan-Chari, J Kim, SA Mousa Thrombosis research 155, 128-130, 2017 | 4 | 2017 |
| Ciraparantag. Heparin neutralizer, anticoagulant reversal agent V Muralidharan-Chari, SA Mousa Drugs of the Future 41 (6), 2016 | 4 | 2016 |
| Method for detecting invasive microvesicles derived from tumor cells C D'Souza-Schorey, JW Clancy, V Muralidharan-Chari US Patent 8,420,334, 2013 | 3 | 2013 |
| Interface between Thrombosis, Inflammation, and Angiogenesis in Cancer Progression SA Mousa, V Muralidharan-Chari, PJ Davis Anti-Angiogenesis Strategies in Cancer Therapeutics, 51-68, 2017 | 2 | 2017 |
| In Tumor Cell Invasion and Extracellular Signal-Regulated Kinase Activation H HoovER, V Muralidharan-Chari, S Tague J Cell Biol 139, 1119-1135, 2005 | 1 | 2005 |
